This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Honeymoon cystitis

Authoring team

Honeymoon cystitis

  • the pathogenic role of S. saprophyticus in UTIs (sometimes referred to as "honeymoon cystitis") was described in the 1960s and since then, more and more evidence was found regarding the pathogenesis of this disease (1)
    • most of epidemiological studies estimate S. saprophyticus as causative agents in 5-20% of UTIs, however, a study from Sweden found that this pathogen
      was the etiological agent in > 40% of uncomplicated UTIs in females

  • Staphylococcus saprophyticus
    • is a Gram-positive, coagulase-negative, non-hemolytic coccus that is a common cause of uncomplicated urinary tract infections (UTIs), particularly in young sexually active females (2)
    • is the second most common cause of community-acquired urinary tract infections, after Escherichia coli
    • over 40% of all young, sexually active women contain S. saprophyticus as part of their normal genitourinary flora (2)

  • antibiotic of choice in uncomplicated S. saprophyticus UTIs is nitrofurantoin 100 mg orally twice daily for five days, or for seven days in complicated cases (2)

Reference:

  • Gajdacs M et al. Increasing relevance of Gram-positive cocci in urinary tract infections: a 10-year analysis of their prevalence and resistance trends.Sci Rep 10, 17658 (2020). https://doi.org/10.1038/s41598-020-74834-y
  • Ehlers S, Merrill SA. Staphylococcus Saprophyticus. [Updated 2021 Jul 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.